ArticleJournal of the American Heart Association2018
Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014.
Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04476524 (Clinical and Economic Impact of an Organized Treatment Pathway on Atrial Fibrillation Patient Management From the Emergency Room), which is not on this map. Cited by 54 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical and Economic Impact of an Organized Treatment Pathway on Atrial Fibrillation Patient Management From the Emergency Room
Who cites it
54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 123 citations in OpenAlex.
- Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials.Cardiovascular drugs and therapy · 2023 · on this mapPooled it
- Reappraising the role of class Ic antiarrhythmics in atrial fibrillation.European journal of clinical pharmacology · 2022Pooled it
- Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 Study.Journal of cardiovascular electrophysiology · 2026Trial
- Artificial Intelligence Software for Detecting Paroxysmal Atrial Fibrillation from Sinus Rhythm Monitor ECG: Development and Clinical Trial.Advances in therapy · 2026Trial
- Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial.BMJ (Clinical research ed.) · 2025Trial
- Decision Support Intervention and Anticoagulation for Emergency Department Atrial Fibrillation: The O'CAFÉ Stepped-Wedge Cluster Randomized Clinical Trial.JAMA network open · 2024Trial
- Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome.European journal of preventive cardiology · 2024Trial
- Article
- Acute atrial fibrillation and flutter treated electively: rationale and design of the randomized controlled AFFELECT trial.European heart journal open · 2026Article
- Observational
- Trends and Predictors of Emergency Department Outcomes in Atrial Fibrillation: A Statewide Analysis from North Carolina-2016 to 2023.Journal of the American College of Emergency Physicians open · 2026Article
- Pre-stroke emergency department utilization in the Brain Attack Surveillance in Corpus Christi (BASIC) project.The American journal of emergency medicine · 2026Article
- Article
- Impact of a care process model on outcomes in emergency department patients with atrial fibrillation.Heart rhythm O2 · 2025Article
- Predicting the spontaneous cardioversion of atrial fibrillation using artificial intelligence-enabled electrocardiography.European heart journal. Digital health · 2025Article
- Atrial fibrillation in the emergency department: Predictors of admission and discharge-A nationwide analysis.Heart rhythm O2 · 2025Article
- Atrial fibrillation in the Americas.Lancet regional health. Americas · 2025Review
- Atrial fibrillation patients presenting to an emergency department successfully managed with a next-day community follow-up pathway: A before-and-after cohort study.Emergency medicine Australasia : EMA · 2025Article
- Efficacy and Safety of Intravenous Diltiazem Versus Metoprolol in the Management of Atrial Fibrillation with Rapid Ventricular Response in the Emergency Department: A Comprehensive Umbrella Review of Systematic Reviews and Meta-analyses.The Journal of innovations in cardiac rhythm management · 2024Review
- Impact of an Organized Treatment Pathway on Management of Atrial Fibrillation: The ER2EP Study.JACC. Advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) is an increasingly prevalent public health problem and one of the most common causes of emergency department (ED) visits. We aimed to investigate the trends in ED visits and hospital admissions for AF. METHODS AND
resultsThis is a repeated cross-sectional analysis of ED visit-level data from the Nationwide Emergency Department Sample for 2007 to 2014. We identified adults who visited EDs in the United States, with a principal diagnosis of AF. A sample of 864 759 ED visits for AF, representing a weighted total of 3 886 520 ED visits, were analyzed. The annual ED visits for AF increased by 30.7% from 411 406 in 2007 (95% confidence interval, 389 819-432 993) to 537 801 (95% confidence interval, 506 747-568 855) in 2014. Patient demographics remained consistent, with an average age of 69 to 70 years and slight female predominance (51%-53%) throughout the study period. Hospital admission rates were stable at ≈70% between 2007 and 2010, after which they gradually declined to 62% in 2014 (
conclusionsAnnual ED visits and hospital admissions for AF increased significantly between 2007 and 2014, despite a reduction in admission rates. These data emphasize the need for widespread implementation of effective strategies aimed at improving the management of patients with AF to reduce hospital admissions and the economic burden of AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.